Robert Lechleider
CIK 1997584 · View on SEC EDGAR ↗
First SEC filing: June 29, 2026 · Latest: June 29, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 2, 2026 | IMNM | S 10b5-1 | 16,072 | $23.44 | $376,728 | 15,805 Direct | -50.42% | Disposed | 23.5% (price as of 2026-08-19) |
| July 2, 2026 | IMNM | S 10b5-1 | 16,214 | $22.76 | $369,031 | 31,877 Direct | -33.72% | Disposed | 27.2% (price as of 2026-08-19) |
| July 2, 2026 | IMNM | S 10b5-1 | 22,714 | $21.95 | $498,572 | 48,091 Direct | -32.08% | Disposed | 31.9% (price as of 2026-08-19) |
| June 25, 2026 | IMNM | S 10b5-1 | 14,420 | $20.66 | $297,917 | 15,805 Direct | -47.71% | Disposed | 40.2% (price as of 2026-08-19) |
| June 25, 2026 | IMNM | S 10b5-1 | 40,580 | $19.56 | $793,745 | 30,225 Direct | -57.31% | Disposed | 48.1% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 23, 2026 | IMNM | Employee Stock Option (right to buy) | Common Stock (108,000) | $22.01 | July 22, 2036 | 108,000 | Acquired |
| July 2, 2026 | IMNM | Employee Stock Option (right to buy) | Common Stock (55,000) | $8.73 | Oct. 26, 2033 | 55,000 | Disposed |
| June 25, 2026 | IMNM | Employee Stock Option (right to buy) | Common Stock (55,000) | $8.73 | Oct. 26, 2033 | 55,000 | Disposed |
| Oct. 27, 2023 | IMNM | Stock option (right to buy) | Common Stock (400,000) | $8.73 | Oct. 26, 2033 | 400,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
IMNM
M.D.Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $530,300 | — | — | $1,897,525 | $307,600 | — | $12,193 | $2,747,618 |
| 2023 | $101,042 | $50,000 | — | $2,706,000 | $58,320 | — | — | $2,915,362 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.